Source: International Congress 2014 – ILDs 5
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Otoshi, R. Kato, R. Shimizu, D. Hujimoto, T. Kawamura, K. Tamai, T. Matsumoto, K. Nagata, K. Otsuka, A. Nakagawa, K. Otsuka, K. Tomii (2-1-1 Minatojima-minamimachi, Chuo-ku, Kobe, Japan). Clinical features and outcomes of patients with diffuse alveolar hemorrhage during antithrombotic therapy. Eur Respir J 2014; 44: Suppl. 58, 3776

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia Source: International Congress 2014 – ILDs 2 Year: 2014 Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid Source: International Congress 2014 – ILDs 1 Year: 2014 BAL findings in desquamative interstitial pneumonia (DIP) and other idiopathic interstitial pneumonia (IIP) Source: International Congress 2014 – ILDs 4 Year: 2014 Multiple segmental lavage in the treatment of pulmonary alveolar proteinosis Source: International Congress 2014 – ILDs 6 Year: 2014 Relation of cytokine expression profile of T-cells from blood and bronchoalveolar lavage fluid with HRCT pattern in fibrosing interstitial lung diseases Source: International Congress 2014 – ILDs 3 Year: 2014 Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results Source: International Congress 2014 – ILDs 3 Year: 2014 Clinical and immunological parameters in patients with newly diagnosed sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Clinical features of four children with pulmonary alveolar proteinosis Source: International Congress 2014 – ILDs 5 Year: 2014 Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 6 Year: 2014 Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome Source: International Congress 2014 – ILDs 1 Year: 2014 Cytokine expression profiles of lymphocytes from bronchoalveolar lavage fluid and blood in patients with interstitial lung diseases(ILDs) Source: International Congress 2014 – ILDs 5 Year: 2014 Sirolimus induced diffuse alveolar hemorrhage: A case report Source: International Congress 2016 – Orphan diseases II Year: 2016 Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 5 Year: 2014 Serum procalcitonin is useful in differentiating between drug-induced pneumonitis and bacterial pneumonia Source: International Congress 2014 – ILDs 5 Year: 2014 Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome Source: International Congress 2014 – ILDs 2 Year: 2014 A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – IPF and surroundings Year: 2014 Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia Source: International Congress 2014 – ILDs 4 Year: 2014 Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 6 Year: 2014 Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone Source: International Congress 2014 – Clinical trials in IPF Year: 2014